Nexien BioPharma (NXEN) Short Interest Ratio & Short Volume

Short interest is the volume of Nexien BioPharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 28,900 shares of NXEN short. Learn More on Nexien BioPharma's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NXEN shares currently have a short interest ratio of 1.0. Learn More on Nexien BioPharma's short interest ratio.

Nexien BioPharma saw a increase in short interest in April. As of April 15th, there was short interest totaling 28,900 shares, an increase of 28,800.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Nexien BioPharma: Biodexa Pharmaceuticals Plc (14.70%), Baudax Bio, Inc. (1.11%), GlobeStar Therapeutics Co. (0.01%), SciSparc Ltd. (21.38%), Neptune Wellness Solutions Inc (0.54%), China SXT Pharmaceuticals, Inc. (11.61%), RespireRx Pharmaceuticals Inc. (0.00%), NeuBase Therapeutics, Inc. (0.81%), 180 Life Sciences Corp. (3.30%), GRI Bio, Inc. (0.61%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

Short selling NXEN is an investing strategy that aims to generate trading profit from Nexien BioPharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Nexien BioPharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NXEN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NXEN, twice per month. The most recent reporting period available is April, 15 2024.